Page results
-
At UCLH, we are extremely proud of our staff and their dedication to delivering the best care for our patients. If you have been treated or looked after by an exceptional member of staff, or a volunteer, we would love you to tell us about it.
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.
-
Information about the elected council of governors for UCLH - patient governors
-
Dental extractions: post-operative instructions patient information page.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
-
Congratulations to everyone who took part in the Royal Parks Half Marathon last weekend to support UCLH.
-
Abbott are running free virtual education sessions for those using the Libre 2 sensors. These sessions are for those new to Libre 2, existing users, friends, family or carers.
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
File results
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0380 - Appraisal review/ Responsible Officer/ Revalidation Officer
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0393 - Translation service/ communication spend
-
FOI/2024/0394 - Private maternity services 2012, 2016, 2018, 2022 and 2023
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy
-
FOI/2024/0400 - Gestational Diabetes Mellitus (GDM) screening and fetal outcomes